STUDIES ON THE DEVELOPMENT OF METHODS TO REMOVE THE MUTANT MITOCHONDRIAL GENOME FOR THERAPY OF MITOCHONDRIAL DESEASE

开发去除突变线粒体基因组用于治疗线粒体疾病的方法的研究

基本信息

  • 批准号:
    08457196
  • 负责人:
  • 金额:
    $ 5.06万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1998
  • 项目状态:
    已结题

项目摘要

Several mutations in the mitochondrial genome are responsible for mitochondrial encephalomyopathy. It is in principle impossible to cure the disease by introducing normal genes into affected cells, because of the multicopic mitochondrial genome, and because of greater propagation of the mutant genome than of the normal one. Thus, if the cells accumulated with mutant mtDNA can be eliminated by apoptosis, the mutant mtDNA was removed with the cells themselves, and expectedly compensate by growing the normal cells. For this purpose, we found that Fas gene responds against mitochondrial dysfunction. In addition, three genes that express more by the mitochondrial dysfunction are isolated by the differential display method. One is a kind DNA ligase and another belongs to the DNA modifying enzyme, and the other is novel gene.In studies on apoptosis, structure of a regulator of apoptosis, Bcl-x was determined by x-ray crystallography and the structure of Bax, an inducer of apoptosis was modeled by the analogy modeling method. The structure of Bax was speculated to have a pore forming domain, and turned out to be responsible for apoptosis. Without the dimer forming domains with the other BcI-2 family proteins, only the pore forming domain induced apoptosis. This finding indicates that the pore forming domain should be a good protein for inducing apoptosis in the cells accumulated with the mutant mitochondrial DNA.Furthermore, in order to find the molecular mechanism of the pathogenesis of mitochondrial encephalomyopathy, the mutant mitochondrial tRNAs were purified and determined the nucleotide sequences, including modified bases. We found that the first letters of the anticodon are commonly deficient in the modification. This result suggest that this defect on the modification causes misincorporahion of amino acid into the proteins encoded by the mitochondria genome, indicating the novel method to cure the disease by forced modification of anticodon.
线粒体基因组中的几个突变是线粒体脑肌病的原因。由于线粒体基因组是多位点的,而且突变基因组比正常基因组繁殖得更快,因此原则上不可能通过将正常基因导入患病细胞来治愈疾病。因此,如果积累有突变mtDNA的细胞可以通过凋亡消除,那么突变mtDNA与细胞本身一起被去除,并通过生长正常细胞来补偿。为此,我们发现Fas基因对抗线粒体功能障碍。此外,通过差异显示方法,分离了三个因线粒体功能障碍而表达更多的基因。在细胞凋亡的研究中,用X射线晶体学方法测定了细胞凋亡调控因子Bcl-x的结构,用类比模拟法模拟了细胞凋亡诱导因子Bax的结构。推测Bax的结构具有孔形成结构域,并且被证明负责细胞凋亡。在没有与其他BcI-2家族蛋白的二聚体形成结构域的情况下,仅孔形成结构域诱导细胞凋亡。这一发现表明,孔形成结构域是一个很好的蛋白质,诱导细胞凋亡的积累与突变的线粒体DNA。此外,为了寻找线粒体脑肌病发病的分子机制,突变的线粒体tRNA的纯化和确定的核苷酸序列,包括修改的碱基。我们发现反密码子的第一个字母通常在修饰中有缺陷。这一结果表明,这种修饰上的缺陷导致氨基酸错配到线粒体基因组编码的蛋白质中,提示通过强制性反密码子修饰来治疗疾病的新方法。

项目成果

期刊论文数量(80)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yasukawa T., Ohta S.et al.: "Stability of mitochondrial tRNA molecules with pathogenic point mutations." Nucleic Acids Symposium series.39. 257-258 (1998)
Yasukawa T.、Ohta S.et al.:“具有致病性点突变的线粒体 tRNA 分子的稳定性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ishibashi Y., Ohta S.et al.: "Pore formation Domain of human pro-apoptotic Bax induces mammalian apoptosis as well as bacterial death without antogonizing anti-apoptotic facrors." Biochem Biophys Res Commun.245. 609-616 (1998)
Ishibashi Y.、Ohta S.等人:“人促凋亡 Bax 的孔形成结构域诱导哺乳动物细胞凋亡以及细菌死亡,而不拮抗抗细胞凋亡因子。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Grillot D.A., Ohta S.et al.: "Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene." J Immunol.158. 4750-4757 (1997)
Grillot D.A.、Ohta S.et al.:“小鼠 bcl-x 基因的基因组组织、启动子区域分析和染色体定位。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Asoh S., Ohta S.et al.: "Expression of the apoptosis-mediator Fas is enhanced by dysfunctional mitochondria." J.Biochem.120. 600-607 (1996)
Asoh S.、Ohta S.et al.:“功能失调的线粒体增强了细胞凋亡介体 Fas 的表达。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
太田成男, 石橋佳朋: "アポトーシスの分子機構. 「脳と発達」" 日本小児神経学会, 7 (1999)
N. Ota,Yoshitomo Ishibashi:“细胞凋亡的分子机制。‘大脑与发育’”日本儿童神经病学学会,7 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OHTA Shigeo其他文献

OHTA Shigeo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OHTA Shigeo', 18)}}的其他基金

Protective effects of hydrogen against irradiation
氢气对辐射的防护作用
  • 批准号:
    24651055
  • 财政年份:
    2012
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Preventive effects of geriatric and life-style related diseases by oral administration of a novel hydrogen-producing material
口服新型产氢材料对老年和生活方式相关疾病的预防作用
  • 批准号:
    23300257
  • 财政年份:
    2011
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development toward preventive application of molecular hydrogen with a novel concept for lifestyle-related diseases
以新概念开发分子氢预防性应用,治疗生活方式相关疾病
  • 批准号:
    20300230
  • 财政年份:
    2008
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a novel therapy for brain infarction using a cell-penetrating protein exhibiting enhanced anti-cell death activity
使用具有增强抗细胞死亡活性的细胞穿透蛋白开发脑梗塞新疗法
  • 批准号:
    16390257
  • 财政年份:
    2004
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Aldehydes accumulated in mitochondria as risk factors to neurodegenerative diseases
线粒体中积累的醛是神经退行性疾病的危险因素
  • 批准号:
    12470144
  • 财政年份:
    2000
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The molecular basis of the higher function of RNA molecules
RNA分子高级功能的分子基础
  • 批准号:
    09278104
  • 财政年份:
    1997
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas (A)
Molecular Pathology on Mitochondrial Encepholomyopathy
线粒体脑肌病的分子病理学
  • 批准号:
    04670151
  • 财政年份:
    1992
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Construction of transgenic mice into which mutant mitochondrial DNA is artificially introduced.
人工引入突变线粒体 DNA 的转基因小鼠的构建。
  • 批准号:
    04557012
  • 财政年份:
    1992
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Cloning Regulatory Genes for Proliferation of Mitochondria and Effects on Mitochondrial Disease
克隆线粒体增殖调控基因及其对线粒体疾病的影响
  • 批准号:
    01570141
  • 财政年份:
    1989
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了